{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:24:23Z","timestamp":1771467863698,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03430-1","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T08:03:13Z","timestamp":1730448193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of topical spironolactone versus topical dapsone in the treatment of acne vulgaris"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1752-0171","authenticated-orcid":false,"given":"Khaled","family":"Gharib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Samir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gehad","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-9748","authenticated-orcid":false,"given":"Mahmoud A.","family":"Rageh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"3430_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pdpdt.2016.04.005","volume":"14","author":"U Keyal","year":"2016","unstructured":"Keyal U, Bhatta AK, Wang XL (2016) Photodynamic therapy for the treatment of different severity of acne: a systematic review. Photodiagnosis Photodyn Ther 14:191\u2013199. https:\/\/doi.org\/10.1016\/j.pdpdt.2016.04.005","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"3430_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjd.13462","volume":"1","author":"JK Tan","year":"2015","unstructured":"Tan JK, Bhate K (2015) A global perspective on the epidemiology of acne. Br J Dermatol 172 Suppl 1:3\u201312. https:\/\/doi.org\/10.1111\/bjd.13462","journal-title":"Br J Dermatol 172 Suppl"},{"key":"3430_CR3","doi-asserted-by":"publisher","first-page":"893080","DOI":"10.1155\/2010\/893080","volume":"2010","author":"G Fabbrocini","year":"2010","unstructured":"Fabbrocini G, Annunziata MC, D\u2019Arco V et al (2010) Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract 2010:893080. https:\/\/doi.org\/10.1155\/2010\/893080","journal-title":"Dermatol Res Pract"},{"issue":"2","key":"3430_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/jid.2010.264","volume":"131","author":"JA Halvorsen","year":"2011","unstructured":"Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L (2011) Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol 131(2):363\u2013370. https:\/\/doi.org\/10.1038\/jid.2010.264","journal-title":"J Invest Dermatol"},{"issue":"5","key":"3430_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ et al (2016) Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 74(5):945\u201373e33. https:\/\/doi.org\/10.1016\/j.jaad.2015.12.037","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"3430_CR6","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/jocd.14011","volume":"20","author":"T Searle","year":"2021","unstructured":"Searle T, Al-Niaimi F, Ali FR (2021) Dapsone for acne: still in use after half a century! J Cosmet Dermatol 20(7):2036\u20132039. https:\/\/doi.org\/10.1111\/jocd.14011","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"3430_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/ijd.14761","volume":"59","author":"N Ghaoui","year":"2020","unstructured":"Ghaoui N, Hanna E, Abbas O, Kibbi AG, Kurban M (2020) Update on the use of dapsone in dermatology. Int J Dermatol 59(7):787\u2013795. https:\/\/doi.org\/10.1111\/ijd.14761","journal-title":"Int J Dermatol"},{"issue":"1","key":"3430_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40257-016-0242-0","volume":"18","author":"ZT Al-Salama","year":"2017","unstructured":"Al-Salama ZT, Deeks ED (2017) Dapsone 7.5% gel: a review in Acne Vulgaris. Am J Clin Dermatol 18(1):139\u2013145. https:\/\/doi.org\/10.1007\/s40257-016-0242-0","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"3430_CR9","doi-asserted-by":"publisher","first-page":"e0298155","DOI":"10.1371\/journal.pone.0298155","volume":"19","author":"MA Basendwh","year":"2024","unstructured":"Basendwh MA, Alharbi AA, Bukhamsin SA, Abdulwahab RA, Alaboud SA (2024) The efficacy of topical clascoterone versus systematic spironolactone for treatment of acne vulgaris: a systematic review and network meta-analysis. PLoS ONE 19(5):e0298155. https:\/\/doi.org\/10.1371\/journal.pone.0298155","journal-title":"PLoS ONE"},{"issue":"12","key":"3430_CR10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/1346-8138.15113","volume":"46","author":"N Chottawornsak","year":"2019","unstructured":"Chottawornsak N, Chongpison Y, Asawanonda P, Kumtornrut C (2019) Topical 2% ketoconazole cream monotherapy significantly improves adult female acne: a double-blind, randomized placebo-controlled trial. J Dermatol 46(12):1184\u20131189. https:\/\/doi.org\/10.1111\/1346-8138.15113","journal-title":"J Dermatol"},{"issue":"6","key":"3430_CR11","first-page":"SF350992s7","volume":"22","author":"H Peterson","year":"2023","unstructured":"Peterson H, Kircik L, Armstrong AW (2023) Clascoterone cream 1%: mechanism of Action, Efficacy, and Safety of a Novel, First-in-class Topical Antiandrogen Therapy for Acne. J Drugs Dermatol 22(6):SF350992s7\u2013SF350992s14","journal-title":"J Drugs Dermatol"},{"issue":"2 Pt 1","key":"3430_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0190-9622(91)70034-y","volume":"24","author":"JC Shaw","year":"1991","unstructured":"Shaw JC (1991) Spironolactone in dermatologic therapy. J Am Acad Dermatol 24(2 Pt 1):236\u2013243. https:\/\/doi.org\/10.1016\/0190-9622(91)70034-y","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3430_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","volume":"18","author":"AM Layton","year":"2017","unstructured":"Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ (2017) Oral spironolactone for Acne Vulgaris in Adult females: a hybrid systematic review. Am J Clin Dermatol 18(2):169\u2013191. https:\/\/doi.org\/10.1007\/s40257-016-0245-x","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"3430_CR14","doi-asserted-by":"publisher","first-page":"e14680","DOI":"10.1111\/dth.14680","volume":"34","author":"R Dhurat","year":"2021","unstructured":"Dhurat R, Shukla D, Lim RK, Wambier CG, Goren A (2021) Spironolactone in adolescent acne vulgaris. Dermatol Ther 34(1):e14680. https:\/\/doi.org\/10.1111\/dth.14680","journal-title":"Dermatol Ther"},{"issue":"2","key":"3430_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/1346-8138.16637","volume":"50","author":"ST Rehan","year":"2023","unstructured":"Rehan ST, Khan Z, Abbas S et al (2023) Role of topical spironolactone in the treatment of acne: a systematic review of clinical trials-does this therapy open a path towards favorable outcomes? J Dermatol 50(2):166\u2013174. https:\/\/doi.org\/10.1111\/1346-8138.16637","journal-title":"J Dermatol"},{"issue":"3","key":"3430_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/0378-6323.51258","volume":"75","author":"B Adityan","year":"2009","unstructured":"Adityan B, Kumari R, Thappa DM (2009) Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol 75(3):323\u2013326. https:\/\/doi.org\/10.4103\/0378-6323.51258","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1 Suppl","key":"3430_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"H Gollnick","year":"2003","unstructured":"Gollnick H, Cunliffe W, Berson D et al (2003) Management of acne: a report from a Global Alliance to Improve outcomes in Acne. J Am Acad Dermatol 49(1 Suppl):S1\u2013S37. https:\/\/doi.org\/10.1067\/mjd.2003.618","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3430_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","volume":"156","author":"A Hebert","year":"2020","unstructured":"Hebert A, Thiboutot D, Stein Gold L et al (2020) Efficacy and Safety of Topical Clascoterone Cream, 1%, for treatment in patients with facial acne: two phase 3 Randomized clinical trials. JAMA Dermatol 156(6):621\u2013630. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0465","journal-title":"JAMA Dermatol"},{"issue":"8","key":"3430_CR19","doi-asserted-by":"publisher","first-page":"e17606","DOI":"10.7759\/cureus.17606","volume":"13","author":"A Noaimi","year":"2021","unstructured":"Noaimi A, Al-Saadi SR (2021) Treatment of Acne Vulgaris by Topical Spironolactone Solution compared with clindamycin solution. Cureus 13(8):e17606. https:\/\/doi.org\/10.7759\/cureus.17606","journal-title":"Cureus"},{"issue":"7","key":"3430_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/cvr\/cvy092","volume":"114","author":"CDCC van der Heijden","year":"2018","unstructured":"van der Heijden CDCC, Deinum J, Joosten LAB, Netea MG, Riksen NP (2018) The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis. Cardiovasc Res 114(7):944\u2013953. https:\/\/doi.org\/10.1093\/cvr\/cvy092","journal-title":"Cardiovasc Res"},{"issue":"3","key":"3430_CR21","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1002\/hsr2.317","volume":"4","author":"A Ayatollahi","year":"2021","unstructured":"Ayatollahi A, Samadi A, Bahmanjahromi A, Robati RM (2021) Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: a pilot study. Health Sci Rep 4(3):e317. https:\/\/doi.org\/10.1002\/hsr2.317","journal-title":"Health Sci Rep"},{"issue":"1","key":"3430_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/09546634.2010.488260","volume":"23","author":"BM Afzali","year":"2012","unstructured":"Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA (2012) Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat 23(1):21\u201325. https:\/\/doi.org\/10.3109\/09546634.2010.488260","journal-title":"J Dermatolog Treat"},{"key":"3430_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.colsurfb.2016.05.042","volume":"146","author":"HR Kelidari","year":"2016","unstructured":"Kelidari HR, Saeedi M, Hajheydari Z et al (2016) Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: a randomized, double-blind, prospective trial. Colloids Surf B Biointerfaces 146:47\u201353. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.05.042","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"9","key":"3430_CR24","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1517\/14656560903002097","volume":"10","author":"A Pickert","year":"2009","unstructured":"Pickert A, Raimer S (2009) An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Expert Opin Pharmacother 10(9):1515\u20131521. https:\/\/doi.org\/10.1517\/14656560903002097","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"3430_CR25","first-page":"783","volume":"10","author":"E Tanghetti","year":"2011","unstructured":"Tanghetti E, Dhawan S, Green L et al (2011) Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris. J Drugs Dermatol 10(7):783\u2013792","journal-title":"J Drugs Dermatol"},{"key":"3430_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/2277-9175.139413","volume":"3","author":"G Faghihi","year":"2014","unstructured":"Faghihi G, Rakhshanpour M, Abtahi-Naeini B, Nilforoushzadeh MA (2014) The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: a randomized double-blind study. Adv Biomed Res 3:177. https:\/\/doi.org\/10.4103\/2277-9175.139413","journal-title":"Adv Biomed Res"},{"issue":"10","key":"3430_CR27","first-page":"981","volume":"6","author":"AW Lucky","year":"2007","unstructured":"Lucky AW, Maloney JM, Roberts J et al (2007) Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. J Drugs Dermatol 6(10):981\u2013987","journal-title":"J Drugs Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03430-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:07:55Z","timestamp":1732205275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03430-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3430"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03430-1","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Zagazig University. Written informed consents were taken from all participants for publishing the study and any associated photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"732"}}